TY - JOUR
T1 - Release of daptomycin from polymethylmethacrylate beads in a continuous flow chamber
AU - Hall, Emily W.
AU - Rouse, Mark S.
AU - Jacofsky, David J.
AU - Osmon, Douglas R.
AU - Hanssen, Arlen D.
AU - Steckelberg, James M.
AU - Patel, Robin
N1 - Funding Information:
This study was supported by Cubist Pharmaceuticals and Mayo Foundation.
PY - 2004/12
Y1 - 2004/12
N2 - Because daptomycin is active against Gram-positive cocci, it may be useful in the treatment and prevention of bone and joint infections when incorporated into polymethylmethacrylate (PMMA). The release kinetics of daptomycin from PMMA were studied in a continuous flow chamber designed to simulate in vivo conditions. Three-millimeter beads containing 2.5%, 7.5%, and 15.0% daptomycin (weight daptomycin per weight PMMA) were individually placed in a chamber with 1 mL Krebs Ringer buffer flowing at 1 mL/hour. The majority of daptomycin was released in the first 24 hours. The mean peak concentrations were 13.4, 62.3, and 146.7 μg/mL; the mean AUC0-∞ were 30, 272, and 1204 h × μg/mL; and the mean percentages of daptomycin released were 6%, 18%, and 42% for the beads containing 2.5%, 7.5%, and 15.0% daptomycin, respectively. Daptomycin is released from PMMA in a continuous flow chamber at a rate similar to that previously determined by our laboratory for vancomycin.
AB - Because daptomycin is active against Gram-positive cocci, it may be useful in the treatment and prevention of bone and joint infections when incorporated into polymethylmethacrylate (PMMA). The release kinetics of daptomycin from PMMA were studied in a continuous flow chamber designed to simulate in vivo conditions. Three-millimeter beads containing 2.5%, 7.5%, and 15.0% daptomycin (weight daptomycin per weight PMMA) were individually placed in a chamber with 1 mL Krebs Ringer buffer flowing at 1 mL/hour. The majority of daptomycin was released in the first 24 hours. The mean peak concentrations were 13.4, 62.3, and 146.7 μg/mL; the mean AUC0-∞ were 30, 272, and 1204 h × μg/mL; and the mean percentages of daptomycin released were 6%, 18%, and 42% for the beads containing 2.5%, 7.5%, and 15.0% daptomycin, respectively. Daptomycin is released from PMMA in a continuous flow chamber at a rate similar to that previously determined by our laboratory for vancomycin.
UR - http://www.scopus.com/inward/record.url?scp=9944223765&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=9944223765&partnerID=8YFLogxK
U2 - 10.1016/j.diagmicrobio.2004.03.004
DO - 10.1016/j.diagmicrobio.2004.03.004
M3 - Article
C2 - 15582299
AN - SCOPUS:9944223765
SN - 0732-8893
VL - 50
SP - 261
EP - 265
JO - Diagnostic Microbiology and Infectious Disease
JF - Diagnostic Microbiology and Infectious Disease
IS - 4
ER -